FDA Inspection 1015545 — Genzyme Ireland Limited

Genzyme Ireland Limited — FEI 3003809840

The FDA completed an inspection of Genzyme Ireland Limited on June 16, 2017 in Waterford. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Waterford (Ireland)